Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 236,570,914 papers from all fields of science
Search
Sign In
Create Free Account
abobotulinumtoxinA
Known as:
abobotulinum toxin A
, abobotulinumtoxin A
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Broader (1)
Botulinum Toxin Type A
Narrower (2)
Dysport
azzalure
abobotulinumtoxinA 300 UNT Injection [Dysport]
abobotulinumtoxinA 500 UNT Injection
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Economic Analysis of Comprehensive Rehabilitation of Childrenwith Spastic Forms of Cerebral Palsy with and without BotulinumNeurotoxin Type A Injections
Zmanovskaia Va
,
Popkov Da
,
Ai Uzdina
,
Ushakova Sa
,
Levitina Ev
2020
Corpus ID: 213358906
Objective: Conduct a comparative economic analysis of comprehensive rehabilitation for children with CP aged from 2 to 14 years…
Expand
2019
2019
Abobotulinumtoxin A in Idiopathic Hyperactive bladder – ethical issues
C. Chibelean
,
I. Boilă
,
+4 authors
C. Dogăroiu
Romanian Journal of Legal Medicine
2019
Corpus ID: 219938308
2019
2019
New Dysport injection technique
L. Hilton
2019
Corpus ID: 133349301
Researchers using a new technique for injecting abobotulinumtoxinA (Dysport, Galderma) to treat glabellar lines found it might be…
Expand
Review
2018
Review
2018
Switching Botulinum Toxin A Products for Patients with Upper Limb Spasticity or Cervical Dystonia: A Review of Clinical Effectiveness
R. Pohar
,
D. Rabb
2018
Corpus ID: 216960076
Review
2018
Review
2018
Practical use of AbobotulinumtoxinA for the treatment of spasticity in children with cerebral palsy
S. Dorf
,
C. Caldas
,
+7 authors
Arquimedes de Moura Ramos
2018
Corpus ID: 54039207
160 ABSTRACT AbobotulinumtoxinA (ABO) has been used for the treatment of spasticity in children with cerebral palsy (CP). Its use…
Expand
2017
2017
Efficacy and safety of abobotulinumtoxinA ( Dysport ® ) for the treatment of hemiparesis in 1 adults with upper limb spasticity previously treated with botulinum toxin : sub-analysis from 2 a Phase 3…
Christina M. Marciniak
,
P. McAllister
,
+10 authors
J. Gracies
2017
Corpus ID: 266118198
Please cite this article as: Marciniak C, McAllister P, Walker H, Brashear A, Edgley S, Deltombe T, Khatkova S, Banach M, Gul F…
Expand
2017
2017
AAN Updates Guidelines on the Uses of Botulinum Neurotoxin.
J. Wilkes
American Family Physician
2017
Corpus ID: 19919139
In 2008, the American Academy of Neurology (AAN) published guidelines on the use of botulinum neurotoxin. This summary highlights…
Expand
Review
2014
Review
2014
AbobotulinumtoxinA for the treatment of upper limb spasticity
W. Jost
2014
Corpus ID: 53695156
Upper limb spasticity is a common feature of many conditions arising from stroke, brain injury or progressive neurological…
Expand
2012
2012
Comparison of different preparations of botulinumtoxin
K. Brockmann
,
K. Schweitzer
,
G. Beck
,
T. Wächter
2012
Corpus ID: 41467646
Background and Objectives: Botulinum neurotoxin A (BoNT-A) is the fi rst line treatment for cervical dystonia (CD). Three…
Expand
2010
2010
NEUROTOXIN INJECTION FOR MOVEMENT DISORDERS
D. Charles
,
Chandler E. Gill
Continuum
2010
Corpus ID: 495868
The therapeutic use of botulinum neurotoxin has exploded since the first US Food and Drug Administration indication was obtained…
Expand